Lipopolysaccharide-induced preconditioning against ischemic injury is associated with changes in Toll-like receptor 4 expression in the rat developing brain

Pediatric Research

Volumn 70, Issue 1, 2011, Pages 10-14

  Hickey, Edward ^a   Shi, Hui ^b   Van Arsdell, Glen ^a   Askalan, Rand ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPOLYSACCHARIDE; TOLL LIKE RECEPTOR 4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DEVELOPMENT; BRAIN INFARCTION; BRAIN ISCHEMIA; CONTROLLED STUDY; FEMALE; HYPOXIC ISCHEMIC ENCEPHALOPATHY; LOW DRUG DOSE; NEUROPROTECTION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUP (RODENT); RAT;

AGE FACTORS; AGING; ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; BRAIN; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HYPOXIA-ISCHEMIA, BRAIN; LIPOPOLYSACCHARIDES; NEUROPROTECTIVE AGENTS; RATS; RATS, WISTAR; TIME FACTORS; TOLL-LIKE RECEPTOR 4;

EID: 79960286634     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1203/PDR.0b013e31821d02aa     Document Type: Article

References (31)

1. Gidday JM 2006 Cerebral preconditioning and ischaemic tolerance. Natl Rev Neurosci 7:437-448 (Pubitemid 44012284)
2. Rosenzweig HL, Lessov NS, Henshall DC, Minami M, Simon RP, Stenzel-Poore MP 2004 Endotoxin preconditioning prevents cellular inflammatory response during ischemic neuroprotection in mice. Stroke 35:2576-2581 (Pubitemid 39458420)
3. Dirnagl U, Simon RP, Hallenbeck JM 2003 Ischemic tolerance and endogenous neuroprotection. Trends Neurosci 26:248-254 (Pubitemid 36556155)
4. Kitagawa K, Matsumoto M, Tagaya M, Hata R, Ueda H, Niinobe M, Handa N, Ryuzo F, Kimura K 1990 Ischemic tolerance' phenomenon found in the brain. Brain Res 528:21-24 (Pubitemid 20292932)
5. Kitagawa K, Matsumoto M, Kuwabara K, Tagay M, Ohtsuki T, Hata R, Ueda H, Handa N, Kimura K, Kamada T 1991 Ischemic tolerance phenomenon detected in various brain regions. Brain Res 561:203-211
6. Marsh BJ, Williams-Karnesky RL, Stenzel-Poore MP 2009 Toll-like receptor signaling in endogenous neuroprotection and stroke. Neuroscience 158:1007-1020
7. Bastide M, Gele P, Petrault O, Pu Q, Caliz A, Robin E, Deplanque D, Duriez P, Bordet R 2003 Delayed cerebrovascular protective effect of lipopolysaccharide in parallel to brain ischemic tolerance. J Cereb Blood Flow Metab 23:399-405 (Pubitemid 36403021)
8. Bordet R, Deplanque D, Maboudou P, Puisieux F, Pu Q, Robin E, Martin A, Bastide M, Leys D, Lhermitte M, Dupuis B 2000 Increase in endogenous brain superoxide dismutase as a potential mechanism of lipopolysaccharide-induced brain ischemic tolerance. J Cereb Blood Flow Metab 20:1190-1196 (Pubitemid 30636754)
9. Tasaki K, Ruetzler CA, Ohtsuki T, Martin D, Nawashiro H, Hallenbeck JM 1997 Lipopolysaccharide pre-treatment induces resistance against subsequent focal cerebral ischemic damage in spontaneously hypertensive rats. Brain Res 748:267-270 (Pubitemid 27094913)
10. Eklind S, Mallard C, Arvidsson P, Hagberg H 2005 Lipopolysaccharide induces both a primary and a secondary phase of sensitization in the developing rat brain. Pediatr Res 58:112-116 (Pubitemid 40967439)
11. Hickey EJ, You X, Kaimaktchiev V, Stenzel-Poore M, Ungerleider RM 2007 Lipopolysaccharide preconditioning induces robust protection against brain injury resulting from deep hypothermic circulatory arrest. J Thorac Cardiovasc Surg 133:1588-1596 (Pubitemid 46802584)
12. Lesuisse C, Martin LJ 2002 Immature and mature cortical neurons engage different apoptotic mechanisms involving caspase-3 and the mitogen-activated protein kinase pathway. J Cereb Blood Flow Metab 22:935-950 (Pubitemid 34831600)
13. Hu BR, Liu CL, Ouyang Y, Blomgren K, Siesjö BK 2000 Involvement of caspase-3 in cell death after hypoxia-ischemia declines during brain maturation. J Cereb Blood Flow Metab 20:1294-1300
14. Yager JY, Shuaib A, Thornhill J 1996 The effect of age on susceptibility to brain damage in a model of global hemispheric hypoxia-ischemia. Brain Res Dev Brain Res 93:143-154 (Pubitemid 26188240)
15. Lu Y-C, Yeh W-C, Ohashi PS 2008 LPS/TLR4 signal transduction pathway. Cytokine 42:145-151
16. Karikó K, Weissman D, Welsh FA 2004 Inhibition of Toll-like receptor and cytokine signaling-a unifying theme in ischemic tolerance. J Cereb Blood Flow Metab 24:1288-1304 (Pubitemid 39482492)
17. Yager JY, Ashwal S 2009 Animal models of perinatal hypoxic-ischemic brain damage. Pediatr Neurol 40:156-167
18. Rice JE 3rd, Vannucci RC, Brierley JB 1981 The influence of immaturity on hypoxic-ischemic brain damage in the rat. Ann Neurol 9:131-141 (Pubitemid 11191192)
19. Mallard EC, Rehn A, Rees S, Tolcos M, Copolov D 1999 Ventriculomegaly and reduced hippocampal volume following intrauterine growth-restriction: implications for the aetiology of schizophrenia. Schizophr Res 40:11-21 (Pubitemid 29460019)
20. Benders MJ, Groenendaal F, Uiterwaal CS, Nikkels PG, Bruinse HW, Nievelstein RA, de Vries LS 2007 Maternal and infant characteristics associated with perinatal arterial stroke in the preterm infant. Stroke 38:1759-1765 (Pubitemid 46847245)
21. Coats SR, Pham TT, Bainbridge BW, Reife RA, Darveau RP 2005 MD-2 mediates the ability of tetra-acylated and penta-acylated lipopolysaccharides to antagonize Escherichia coli lipopolysaccharide at the TLR4 signaling complex. J Immunol 175:4490-4498 (Pubitemid 41361986)
22. Ikeda T, Yang L, Ikenoue T, Mallard C, Hagberg H 2006 Endotoxin-induced hypoxic-ischemic tolerance is mediated by up-regulation of corticosterone in neonatal rat. Pediatr Res 59:56-60
23. Esen N, Tanga FY, DeLeo JA, Kielian T 2004 Toll-like receptor 2 (TLR2) mediates astrocyte activation in response to the gram-positive bacterium Staphylococcus aureus. J Neurochem 88:746-758 (Pubitemid 38140218)
24. Bsibsi M, Ravid R, Gveric D, Van Noort JM 2002 Broad expression of Toll-like receptors in the human central nervous system. J Neuropathol Exp Neurol 61:1013-1021 (Pubitemid 35278723)
25. Ma Y, Li J, Chiu I, Wang Y, Sloane JA, Lu J, Kosaras B, Sidman RL, Volpe JJ, Vartanian T 2006 Toll-like receptor 8 functions as a negative regulator of neurite outgrowth and inducer of neuronal apoptosis. J Cell Biol 175:209-215 (Pubitemid 44631415)
26. Hua F, Ma J, Ha T, Kelley J, Williams DL, Kao RL, Kalbfleisch JH, Browder IW, Li C 2008 Preconditioning with a TLR2 specific ligand increases resistance to cerebral ischemia/reperfusion injury. J Neuroimmunol 199:75-82
27. Stevens SL, Ciesielski TM, Marsh BJ, Yang T, Homen DS, Boule J-L, Lessov NS, Simon RP, Stenzel-Poore MP 2008 Toll-like receptor 9: a new target of ischemic preconditioning in the brain. J Cereb Blood Flow Metab 28:1040-1047 (Pubitemid 351589642)
28. Cao CX, Yang QW, Lv FL, Cui J, Fu HB, Wang JZ 2007 Reduced cerebral ischemia-reperfusion injury in Toll-like receptor 4 deficient mice. Biochem Biophys Res Commun 353:509-514 (Pubitemid 46023466)
29. McQuillen PS, Barkovich AJ, Hamrick SE, Perez M, Ward P, Glidden DV, Azakie A, Karl T, Miller SP 2007 Temporal and anatomic risk profile of brain injury with neonatal repair of congenital heart defects. Stroke 38:736-741 (Pubitemid 46188253)
30. Miller SP, McQuillen PS, Vigneron DB, Glidden DV, Barkovich AJ, Ferriero DM, Hamrick SE, Azakie A, Karl TR 2004 Preoperative brain injury in newborns with transposition of the great arteries. Ann Thorac Surg 77:1698-1706 (Pubitemid 38530009)
31. Domi T, Edgell DS, McCrindle BW, Williams WG, Chan AK, MacGregor DL, Kirton A, deVeber GA 2008 Frequency, predictors, and neurologic outcomes of vasoocclusive strokes associated with cardiac surgery in children. Pediatrics 122:1292-1298